San Francisco, CA

California CVS Store to Permanently Close October 23rd

Joel Eisenberg
CVS/PharmacyPhoto byShutterstock

Author’s Note

This article is based on corporate postings and accredited media reports. Linked information within this article is attributed to the following outlets:,, and the San Francisco Chronicle.


In recent months, most of my articles on the stalwart CVS/Pharmacy chain have related to the company’s November 18, 2021 announcement of 900 store closures over the ensuing three years, which you can read about on

Now comes word that another longstanding west coast CVS location is permanently closing, per that initiative, as a downtown San Francisco store shutters on October 23rd.

Let us explore.

CVS/Pharmacy, 2023

According to a September 21st report from, as with other recent company closings throughout the U.S., the upcoming San Francisco closure will also see the transference of customer prescriptions to other locations.

As excerpted from the report: The South of Market location is scheduled to close on October 23 with all existing customers being transferred to another location. According to a company spokesperson, all prescriptions will go to the CVS store on Van Ness Avenue.

Quoting a spokesperson who spoke to the San Francisco Chronicle: “Maintaining access to pharmacy services in the communities we serve is an important factor we consider when making store closure decisions.

The upcoming closing is reportedly strategic in nature, and based on a performance review.


This is a developing story. In the event of pertinent updates to this matter, I will share them here on NewsBreak.

Thank you for reading.

This is original content from NewsBreak’s Creator Program. Join today to publish and share your own content.

Comments / 50

Published by

I am an award-winning author, screenwriter for film and television, and producer. My mission on News Break is to share socially important perspectives on both culture and pop-culture. Member of PEN America, and the WGA.

Northridge, CA

More from Joel Eisenberg

Comments / 0